Leonard Weisman
Baylor College of Medicine, USA

Personal Home Page

http://www.neonate.net/about/faculty/weisman/

Articles in Scholarly Journals [Incomplete List]

  1. Neonatal Coinfection Model of Coagulase-Negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: Fluconazole Prophylaxis Enhances Survival and Growth
    Antimicrobial Agents and Chemotherapy, vol. 51, no. 4, pp. 1240–1245, 2007
  2. Lysostaphin in Treatment of Neonatal Staphylococcus aureus Infection
    Antimicrobial Agents and Chemotherapy, vol. 51, no. 6, pp. 2198–2200, 2007
  3. Coagulase-Negative Staphylococcal Infections in the Neonate and Child: An Update
    Seminars in Pediatric Infectious Diseases, vol. 17, no. 3, pp. 120–127, 2006
  4. Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study
    Journal of Clinical Microbiology, vol. 44, no. 4, pp. 1257–1261, 2006
  5. Prevention and treatment of respiratory syncytial virus infection in infants: an update
    Expert Review of Vaccines, vol. 5, no. 2, pp. 261–268, 2006
  6. Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient
    Current Opinion in Infectious Diseases, vol. 17, no. 3, pp. 237–241, 2004
  7. Level of Maternal IgG Anti-Group B Streptococcus Type III Antibody Correlated with Protection of Neonates against Early-Onset Disease Caused by This Pathogen
    The Journal of Infectious Diseases, vol. 190, no. 5, pp. 928–934, 2004
  8. Dexamethasone effects on group B streptococcal infection in newborn rats
    The Pediatric Infectious Disease Journal, vol. 23, no. 1, pp. 47–52, 2004
  9. Necrotizing Enterocolitis and Gastrointestinal Complications After Indomethacin Therapy and Surgical Ligation in Premature Infants With Patent Ductus Arteriosus
    Journal of Perinatology, vol. 23, no. 4, Article ID 7210911, 4 pages, 2003
  10. Prematurity Is the Major Risk Factor for Late-Onset Group B Streptococcus Disease
    The Journal of Infectious Diseases, vol. 188, no. 2, pp. 267–271, 2003
  11. Pediatric Infectious Disease Journal, vol. 22, no. 2, pp. S33–S39, 2003
  12. Current respiratory syncytial virus prevention strategies in high-risk infants
    Pediatrics International, vol. 44, no. 5, pp. 475–480, 2002
  13. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease
    American Journal of Obstetrics and Gynecology, vol. 184, no. 6, pp. 1204–1210, 2001
  14. Level of Maternal Antibody Required to Protect Neonates against Early-Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study
    The Journal of Infectious Diseases, vol. 184, no. 8, pp. 1022–1028, 2001
  15. Antibiotic Susceptibility Profiles for Group B Streptococci Isolated from Neonates, 1995–1998
    Clinical Infectious Diseases, vol. 31, no. 1, pp. 76–79, 2000
  16. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion
    The Pediatric Infectious Disease Journal, vol. 18, no. 3, pp. 223–231, 1999
  17. Future opportunities for nonantibiotic prevention or adjunctive therapy of neonatal bacterial infections
    Seminars in Pediatric Infectious Diseases, vol. 10, no. 2, pp. 130–136, 1999
  18. Currently available nonantibiotic preventive or adjunctive therapy of neonatal bacterial infections
    Seminars in Pediatric Infectious Diseases, vol. 10, no. 2, pp. 97–103, 1999
  19. IMpact-RSV Study Group Report
    PEDIATRICS, vol. 104, no. 4, pp. 993–994, 1999
  20. Questions About Palivizumab (Synagis)
    PEDIATRICS, vol. 103, no. 2, pp. 534–535, 1999
  21. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia
    The Pediatric Infectious Disease Journal, vol. 17, no. 2, pp. 110–115, 1998
  22. Actuarial Survival in the Premature Infant Less Than 30 Weeks' Gestation
    PEDIATRICS, vol. 101, no. 6, pp. 975–978, 1998
  23. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates????
    The Journal of Pediatrics, vol. 125, no. 6, pp. 922–930, 1994
  24. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: A review*1, *2
    Clinical Immunology and Immunopathology, vol. 62, no. 1, pp. S92–S97, 1992
  25. Intravenous immune globulin therapy for early-onset sepsis in premature neonates
    The Journal of Pediatrics, vol. 121, no. 3, pp. 434–443, 1992
  26. Early-onset group B streptococcal sepsis: A current assessment
    The Journal of Pediatrics, vol. 121, no. 3, pp. 428–433, 1992
  27. The Opsonic Antibody Response of Female Rats to Type III Group B Streptococcal Immunization: a Model for Maternal Immunity
    Veterinary Immunology and Immunopathology, vol. 24, no. 1, pp. 79–89, 1990
  28. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats
    The Journal of Pediatrics, vol. 115, no. 3, pp. 445–450, 1989
  29. Clinical Estimation of Liver Size in the Normal Neonate
    Clinical Pediatrics, vol. 21, no. 10, pp. 596–598, 1982